ClinicalTrials.gg
RecruitingNCT07390318BCALSUpdated Sep 24, 2026

Bowel Continence Across the Lifespan in People With Spina Bifida

An observational study in Spina Bifida, Neurogenic Bowel and Bowel Incontinence, sponsored by David Chu. Recruiting at 24 sites in United States. Open to participants aged 5 Years and older. Per ClinicalTrials.gov, last updated 2026-09-24.

Sponsored by David Chu · Observational

From the registry’s dates

  • Started Apr 2026; still recruiting 7 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
943
Ages
5 Years and older
Sex
All
01

Study summary

The goal of this observational study is to learn how different enema programs affect bowel control in children and adults with spina bifida. An enema program involves putting liquid into the large intestine (colon) to help someone poop. The main questions it aims to answer are:

  1. How well do different enema programs prevent bowel accidents?
  2. How do these enema programs affect independence, bowel symptoms, and quality of life?

Researchers will compare two types of enema programs to see which works better and is easier for participants to manage.

Participants starting a new enema program will answer online survey questions at 3 different timepoints over the course of 1 year.

Read the detailed description

Spina bifida is a rare disease affecting an estimated 166,000 people in the United States. Because of the birth defect in the spinal cord, many organ systems do not work properly. Included among these affected organ systems are the bowels or intestines, which can lead to bowel incontinence or bowel accidents. Bowel incontinence is very disruptive to the lives of people with spina bifida by affecting their ability to have romantic relationships, find jobs, and overall enjoy their lives. The spina bifida community has recognized bowel incontinence as a top priority for research.

Typically, reducing bowel incontinence and improving bowel continence occurs in a stepwise fashion. After medications by mouth such as laxatives or stool softeners, 2nd line treatments include enema programs. Two types of enema programs currently exist, those given in either a backward direction (given through the anus or end of the large intestine or colon) or in a forward direction (given through a tube that enters the start of the large intestine or colon). These two types of enema programs have different positives and negatives which have not been compared nor studied well. The lack of evidence on which is the better enema program presents a key decisional dilemma for many people with spina bifida who want to improve their bowel continence.

In the current study, the study team will compare the two types of enema programs in 943 children and adults ages 5 years old and up with spina bifida at 24 centers across the United States. The enema programs will be assigned to and started by the participants as part of usual clinical care from their local clinical team. At 6 months and 12 months over a 1-year study period, the study team will look at how the two types of enema programs compare in bowel continence (how well they work to prevent bowel accidents), quality of life (how much people enjoy their lives), bowel symptoms (how well they work to reduce bowel-related symptoms), self-management and independence (how well people can do these enema programs themselves without help), and healthcare utilization (how often these enema programs cause problems needing medical help). The study team will also ask 20 children with spina bifida, 20 adults with spina bifida, and 20 caregivers of children and adults with spina bifida more detailed interview questions about their lived experiences with managing bowel incontinence and their thoughts on how best to start and maintain a successful enema program. The expected study results will help people with spina bifida not only improve their bowel continence, but also their quality of life.

The study team is working with patient and family partners within the spina bifida community, healthcare providers across numerous disciplines, national advocacy organizations (the Spina Bifida Association), and industry partners who make enema devices to design and conduct this study.

02

Conditions studied

  • Spina Bifida
  • Neurogenic Bowel
  • Bowel Incontinence

Keywords

  • retrograde enema
  • antegrade enema
  • bowel management program
  • bowel continence program
  • self-management
  • quality of life
03

In context

Spinal Dysraphism

142 studies on the registry are indexed under Spinal Dysraphism; 39 are open to participants now.

This study's planned enrollment of 943 is above the median of 105 across 48 observational studies indexed under Spinal Dysraphism.

Browse Spinal Dysraphism studies →

Lead sponsor

This is the only study on the registry with David Chu as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Children, adolescents, and adults age 5 years and older with spina bifida starting a new enema program at one of 24 participating clinical centers in the United States.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Minimum age 5 years old
  • Myelomeningocele diagnosis
  • Starting a retrograde or antegrade enema program (or switching from one enema program to the other)
  • English or Spanish speaking/literate

Exclusion criteria

Exclusion Criteria:

- Other types of spinal dysraphism (e.g., lipomyelomeningocele, fatty filum)

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
943 participants (estimated)
Patient registry
No

Groups and cohorts

  • Retrograde Enema

    Participants starting a retrograde enema program, as part of standard care prescribed by their local clinical team.

    Procedure: Retrograde Enema

  • Antegrade Enema

    Participants starting an antegrade enema program, as part of standard care prescribed by their local clinical team.

    Procedure: Antegrade Enema

Interventions

  • ProcedureRetrograde Enema

    A retrograde enema is a bowel management technique in which the enema is given through the rectum (end of the colon). This includes cone enemas, foley balloon enemas, and Transanal irrigation (e.g. Peristeen, Navina).

  • ProcedureAntegrade Enema

    An antegrade enema is a bowel management technique in which an enema is given through a surgically-created tube that enters at the start of the colon. This includes MACES, cecostomy buttons, and Chait tubes.

06

What researchers measure

Primary outcomes

  1. Bowel continence

    Measured with a single question on bowel incontinence frequency in the past month, with "continence" strictly defined as answering "never": (Daily, Weekly, Monthly, Never)

    Time frame: Before starting enema program, 6 months after starting enema program, 1 year after starting enema program

Secondary outcomes

  1. Bowel symptoms and satisfaction

    Measured using the Neurogenic Bowel Dysfunction (NBD) score. Scores range from 0-47, higher scores mean greater severity of bowel dysfunction.

    Time frame: Before starting enema program, 6 months after starting enema program, 1 year after starting enema program

  2. Disease-specific quality of life

    Measured using the Quality of Life Assessment in Spina Bifida (QUALAS) Child, Teenager, and Adult questionnaires. Scores range from 0-100, higher scores mean better quality of life.

    Time frame: Before starting enema program, 6 months after starting enema program, 1 year after starting enema program

  3. Overall quality of life

    Measured using the Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health and Pediatric Global Health 7 questionnaires. Raw scores are converted into T-scores, which range from 16.2-67.7 for PROMIS Global Health and 16-67.5 for PROMIS Pediatric Global Health 7. Higher scores mean better quality of life.

    Time frame: Before starting enema program, 6 months after starting enema program, 1 year after starting enema program.

  4. Self-management and independence

    Measured using the Adolescent/Young Adult Self-Management and Independence Scale (AMIS) II. Scores range from 36-252, higher scores mean higher level of self-management and independence.

    Time frame: Before starting enema program, 6 months after starting enema program, 1 year after starting enema program

  5. Rate of unplanned healthcare utilization related to bowel issues

    Number of emergency room visits, urgent care or immediate care visits, and urgent outpatient ambulatory visits related to bowel issues.

    Time frame: For 1 year after starting enema program

07

Study locations

23 of 24 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07390318
Lead sponsor
David Chu
Collaborators
Patient-Centered Outcomes Research Institute
Responsible party
David Chu (Principal Investigator; Attending Physician, Urology; Associate Professor of Urology at Northwestern University Feinberg School of Medicine, Ann & Robert H Lurie Children's Hospital of Chicago) — Sponsor-investigator
First posted
Feb 5, 2026
Start date
Apr 1, 2026
Primary completion
May 1, 2030 (estimated)
Completion
May 1, 2030 (estimated)
Last update
Sep 24, 2026

Study contacts

Josephine Hirsch
Contact
jahirsch@luriechildrens.org
312-227-6076
Ilina Rosoklija
Contact
irosoklija@luriechildrens.org
312-227-6409

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion